Corriente Advisors, LLC - AXOVANT GENE THERAPIES LTD ownership

Quarter-by-quarter ownership
Corriente Advisors, LLC ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q3 2020$4,043,000875,0002.05%
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q3 2023.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders